Compile Data Set for Download or QSAR
maximum 50k data
Found 75 Enz. Inhib. hit(s) with all data for entry = 9998
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506772(US11046651, Compound 1)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506778(US11046651, Compound 4)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506781(US11046651, Compound 17)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506782(US11046651, Compound 6)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506783(US11046651, Compound 18)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506790(US11046651, Compound 10)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506794(US11046651, Compound 12)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506772(US11046651, Compound 1)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506773(US11046651, Compound 13)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506774(US11046651, Compound 2)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506775(US11046651, Compound 14)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506776(US11046651, Compound 3)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506777(US11046651, Compound 15)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506778(US11046651, Compound 4)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506780(US11046651, Compound 5)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506781(US11046651, Compound 17)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506782(US11046651, Compound 6)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506784(US11046651, Compound 7)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506785(US11046651, Compound 19)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506788(US11046651, Compound 9)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506790(US11046651, Compound 10)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506792(US11046651, Compound 11)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506798(US11046651, Compound 29)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506799(US11046651, Compound 31)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506800(US11046651, Compound 33)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506801(US11046651, Compound 34)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506793(US11046651, Compound 38)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506795(US11046651, Compound 39)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506797(US11046651, Compound 28)
Affinity DataKi:  37.5nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506776(US11046651, Compound 3)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506786(US11046651, Compound 8)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506785(US11046651, Compound 19)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506802(US11046651, Compound 35)
Affinity DataKi:  37.5nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506774(US11046651, Compound 2)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506789(US11046651, Compound 21)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506787(US11046651, Compound 20)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506780(US11046651, Compound 5)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506783(US11046651, Compound 18)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506773(US11046651, Compound 13)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506786(US11046651, Compound 8)
Affinity DataKi:  46nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506786(US11046651, Compound 8)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506791(US11046651, Compound 37)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506794(US11046651, Compound 12)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506795(US11046651, Compound 39)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506779(US11046651, Compound 16)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506795(US11046651, Compound 39)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506793(US11046651, Compound 38)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506792(US11046651, Compound 11)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506791(US11046651, Compound 37)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistamine H1 receptor(Homo sapiens (Human))
Alairion

US Patent
LigandPNGBDBM506789(US11046651, Compound 21)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 75 total ) | Next | Last >>
Jump to: